Minjie Wei

686 total citations · 1 hit paper
13 papers, 474 citations indexed

About

Minjie Wei is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Minjie Wei has authored 13 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Minjie Wei's work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Antimicrobial Peptides and Activities (2 papers). Minjie Wei is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Antimicrobial Peptides and Activities (2 papers). Minjie Wei collaborates with scholars based in China, Saint Kitts and Nevis and United Kingdom. Minjie Wei's co-authors include Lin Zhao, Huizhe Wu, Zhaojin Yu, Hui Wang, Qinghuan Xiao, Ke Ma, Jiankun Yu, Liang Zou, Marcia Bellon and Jingyi Fan and has published in prestigious journals such as Oncogene, Molecular Cancer and Current Medicinal Chemistry.

In The Last Decade

Minjie Wei

13 papers receiving 471 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals

2025 33 citations Ruili Wang, Chen Mo et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minjie Wei China	9	327	132	82	57	55	13	474
Jaekwang Jeong United States	11	200 0.6×	145 1.1×	45 0.5×	49 0.9×	31 0.6×	19	395
Elangovan Thavathiru United States	12	219 0.7×	92 0.7×	59 0.7×	11 0.2×	18 0.3×	16	371
Wen-Cheng Chung United States	9	218 0.7×	98 0.7×	64 0.8×	11 0.2×	56 1.0×	13	350
Ashkan Shahbandi United States	7	231 0.7×	200 1.5×	124 1.5×	23 0.4×	62 1.1×	11	507
M Kaufmann Germany	10	240 0.7×	142 1.1×	63 0.8×	21 0.4×	25 0.5×	16	406
André Limnander United States	12	242 0.7×	149 1.1×	40 0.5×	20 0.4×	13 0.2×	17	512
Rosalie Joosten Netherlands	9	279 0.9×	261 2.0×	104 1.3×	13 0.2×	28 0.5×	13	528
Zhu‐Ting Tong China	9	299 0.9×	96 0.7×	148 1.8×	18 0.3×	45 0.8×	10	443
Miriam Teeuwssen Netherlands	7	396 1.2×	246 1.9×	160 2.0×	12 0.2×	39 0.7×	8	637
Paula S. Espino Canada	12	458 1.4×	118 0.9×	80 1.0×	14 0.2×	97 1.8×	13	635

Countries citing papers authored by Minjie Wei

Since Specialization

Citations

This map shows the geographic impact of Minjie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjie Wei more than expected).

Fields of papers citing papers by Minjie Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjie Wei. The network helps show where Minjie Wei may publish in the future.

Co-authorship network of co-authors of Minjie Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Minjie Wei. A scholar is included among the top collaborators of Minjie Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjie Wei. Minjie Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Ruili, Chen Mo, Xin Zhao, et al.. (2025). Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals. Journal of Hematology & Oncology. 18(1). 51–51. 33 indexed citations breakdown →

Fan, Jingyi, Marcia Bellon, Mingyi Ju, et al.. (2022). Clinical significance of FBXW7 loss of function in human cancers. Molecular Cancer. 21(1). 87–87. 89 indexed citations

Wu, Huizhe, Xiangyu Ding, Xiao Hu, et al.. (2022). LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer. Oncogene. 41(13). 1959–1973. 20 indexed citations

Lu, Hongyuan, Wenwu Liu, Yuanyuan Yan, et al.. (2022). A Comprehensive Description of Hypoxia-inducible Factor 2α Inhibitorsas Anticancer Agents: A Mini-review. Current Medicinal Chemistry. 30(25). 2835–2849. 3 indexed citations

Li, Zinan, Lifeng Yu, Lin Wang, et al.. (2021). Advances in cancer treatment: a new therapeutic target, Annexin A2. Journal of Cancer. 12(12). 3587–3596. 31 indexed citations

Wang, Xiangyi, et al.. (2021). Recent progress on MHC-I epitope prediction in tumor immunotherapy.. PubMed. 11(6). 2401–2416. 7 indexed citations

Yang, Ying, Mingli Sun, Zhaojin Yu, et al.. (2020). Designing high affinity target-binding peptides to HLA-E: a key membrane antigen of multiple myeloma. Aging. 12(20). 20457–20470. 4 indexed citations

Yan, Yi, Zhaojin Yu, Mingli Sun, et al.. (2019). The Analysis of Key Factors Related to ADCs Structural Design. Frontiers in Pharmacology. 10. 373–373. 51 indexed citations

Wang, Hui, Liang Zou, Ke Ma, et al.. (2017). Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer. Molecular Cancer. 16(1). 152–152. 114 indexed citations

10.

Zhao, Haishan, Zhaojin Yu, Lin Zhao, et al.. (2016). HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Japanese Journal of Clinical Oncology. 46(10). 893–902. 36 indexed citations

11.

Du, Qiang, Xiaojuan Hou, Mei Zhou, et al.. (2014). Cationicity-Enhanced Analogues of the Antimicrobial Peptides, AcrAP1 and AcrAP2, from the Venom of the Scorpion, Androctonus crassicauda, Display Potent Growth Modulation Effects on Human Cancer Cell Lines. International Journal of Biological Sciences. 10(10). 1097–1107. 41 indexed citations

12.

Wang, Hui, Yuxin Wu, Mei Zhou, et al.. (2012). The structures of four bombesins and their cloned precursor-encoding cDNAs from acid-solvated skin secretion of the European yellow-bellied toad, Bombina variegata. Peptides. 36(2). 221–229. 5 indexed citations

13.

Liu, Duo, Hsien–Tsai Wu, Hui Kang, et al.. (2011). DNA repair genes XPC, XPG polymorphisms: Relation to the risk of colorectal carcinoma and therapeutic outcome with oxaliplatin‐based adjuvant chemotherapy. Molecular Carcinogenesis. 51(S1). E83–93. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact